PROPOSAL FOR A PREOPERATIVE FUNCTIONAL OPTIMIZATION PATHWAY FOR PATIENTS CANDIDATE FOR MAJOR SURGERY (CARDIAC AND ABDOMINAL ONCOLOGY) (PRIME CARE)
PRehabilitation With Integrated and Multimodal Evaluation in Cardiac and Abdominal majoR surgEry (PRIME CARE) A Proposed Pathway for Preoperative Functional Optimization in Candidates for Major Surgery
The study aims to evaluate a prehabilitation protocol for patients undergoing cardiac and abdominal surgery. The project for a preparation program for cardiac surgery was developed within the framework of ERAS (Enhanced Recovery After Surgery), which aims to ensure optimal recovery after surgery and a Surgery), which aims to ensure optimal recovery after surgery and an early and safe return to daily activities.
The study focuses on the preoperative phase, with the introduction of the concept of prehabilitation, i.e., a program to enhance the functional abilities of individuals in preparation for major surgery. The study focuses on the preoperative phase, introducing the concept of prehabilitation, i.e., a program to enhance the functional abilities of individuals in preparation for major surgery, such as cardiac surgery, on an elective basis.
This program, which currently represents best clinical practice, lasts four weeks and addresses several areas: strengthening respiratory and muscular functions, optimizing nutrition, and cognitive stimulation. Patients will be assessed at enrollment and up to 180 days post-surgery to evaluate their clinical status compared to pre-surgery on these four aspects mentioned above.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Massimo Stella, MD
- Numero di telefono: 0039 0332393447
- Email: maxstella95@gmail.com
Luoghi di studio
-
-
-
Varese, Italia, 21100
- Attivo, non reclutante
- ASST Sette Laghi
-
-
VA
-
Varese, VA, Italia, 21052
- Reclutamento
- Ospedale di Circolo
-
Contatto:
- Massimo Stella, MD
- Numero di telefono: +39 0332 393447
- Email: maxstella95@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
This prospective, observational, single-center study will enroll approximately 50 adult patients (≥18 years old) undergoing elective cardiac or major abdominal surgery at Ospedale di Circolo e Fondazione Macchi, Varese, Italy. Eligible patients for abdominal surgery must have ASA I-III and PS ECOG ≤2. Key exclusion criteria include emergency surgery, unstable angina, malignant arrhythmias, severe or very severe COPD, dementia, pregnancy, or inability to provide informed consent. Participants will be screened by the surgical team and followed during a personalized prehabilitation program starting about one month before surgery.
Descrizione
Inclusion Criteria:
- Elective major abdominal surgery or elective cardio surgery
- American Society of Anaesthesiologists Physical Status Classification ≤ 3
- Performance Status according to ECOG Scale ≤ 2
Exclusion Criteria:
- Emergency surgery
- Unstable angina
- Malignant arrythmias
- Severe/ very severe COPD
- Dementia
- Pregnancy
- Inability to provide informed consent
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: CASE_ONLY
- Prospettive temporali: PROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
|---|
|
Eligible patients for major surgery
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
10% improvement from baseline at 6-minutes-walking-test-distance
Lasso di tempo: From enrollment to the date of surgery
|
The primary outcome of this study is to evaluate whether prehabilitation translates into an improvement in quality of life before surgery, assessed in terms of functional status. This objective is assessed using the 6-minute walking distance test. A significant improvement is considered to be a positive delta in the six-minute walking test of ≥10% obtained at the assessment performed on the day of admission compared to the value recorded during the first assessment. |
From enrollment to the date of surgery
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Increased thickness of the quadriceps femoris muscle
Lasso di tempo: From enrollment to the date of surgery
|
An increase in the thickness of the quadriceps femoris muscle will be assessed via ultrasound as a direct sign of an increase in the number and volume of muscle fibres |
From enrollment to the date of surgery
|
|
Increased cross-sectional area of the quadriceps femoris muscle
Lasso di tempo: From enrollment to the date of surgery
|
An increase in the cross-sectional area of the quadriceps femoris muscle will be assessed via ultrasound as a direct sign of an increase in the number and volume of muscle fibres |
From enrollment to the date of surgery
|
|
Increased pennation angle of the quadriceps femoris muscle
Lasso di tempo: From enrollment to the date of surgery
|
An increase in the pennation angle of the quadriceps femoris muscle, assessed by ultrasound, is a direct sign of increased contractility of the muscle itself, and therefore an indirect index of an increase in muscle strength. |
From enrollment to the date of surgery
|
|
Change in Pulmonary Function Parameters
Lasso di tempo: From enrollment to the date of surgery
|
Change in pulmonary volumes including Forced Expiratory Volume in 1 second (FEV1), Forced Vital Capacity (FVC), and Tiffeneau Index (FEV1/FVC ratio) measured through spirometry at baseline and after completion of prehabilitation. |
From enrollment to the date of surgery
|
|
Improvement in Functional Performance Tests
Lasso di tempo: From enrollment to the date of surgery
|
Change in performance at Handgrip Strength test (Newton), and Maximal Isometric Strength test (Newton), assessed at baseline and after the prehabilitation program. An increase in the value indicates an improvement in functional capacity. |
From enrollment to the date of surgery
|
|
Change in Diaphragmatic Excursion
Lasso di tempo: From enrollment to the date of surgery
|
Variation in diaphragmatic movement amplitude assessed by ultrasound before and after the prehabilitation period. |
From enrollment to the date of surgery
|
|
Change in Health-Related Quality of Life (EQ-5D-5L Index)
Lasso di tempo: From enrollment to 180 days after discharge
|
Variation in patient-reported quality of life as assessed by the EQ-5D-5L questionnaire. The index score will be compared between baseline and preoperative assessment after prehabilitation and also at 30 days and 180days after discharge |
From enrollment to 180 days after discharge
|
|
Incidence of Postoperative Delirium in the Intensive Care Unit
Lasso di tempo: Perioperative/Periprocedural
|
Occurrence of postoperative delirium evaluated daily during ICU stay using the Confusion Assessment Method for the ICU (CAM-ICU). |
Perioperative/Periprocedural
|
|
Change in Nutritional and Biochemical Markers
Lasso di tempo: From enrollment to 30 days after discharge
|
Variation in nutritional status indicators assessed through blood biochemical parameters (albumin, prealbumin, total protein, lymphocyte count, iron, transferrin, vitamin B12, folic acid, hemoglobin,) before the prehabilitation program, after the prehabilitation program and at 30 days after discharge |
From enrollment to 30 days after discharge
|
|
Length of Stay in Intensive Care Unit
Lasso di tempo: Perioperative/Periprocedural
|
Duration of ICU stay (in days) from postoperative admission to ICU discharge. |
Perioperative/Periprocedural
|
|
Total Hospital Length of Stay
Lasso di tempo: Perioperative/Periprocedural
|
Total duration of hospitalization (in days) from admission for surgery to hospital discharge. |
Perioperative/Periprocedural
|
|
180-Day Mortality
Lasso di tempo: From discharge to 180 days after surgery
|
All-cause mortality evaluated at 180 days after surgery. |
From discharge to 180 days after surgery
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 25/2025
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- ICF
- CODICE_ANALITICO
- RSI
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .